Olema Pharmaceuticals signs $18.5M lease for new headquarters, relocating by December 2026

Filed May 1, 2026 · Period ending April 27, 2026 · ~1 min read

Key Changes

• high

  Company entered 7-year lease for 38,176 sq ft headquarters space with total base rent of $18.5M, representing material long-term financial commitment. Relocation planned by December 2026 as existing San Francisco leases expire.

  Item 1.01 verify on EDGAR →
• high

  Lease creates direct financial obligation disclosed under Item 2.03. Total commitment includes $12.4M for Phase I and $6.1M for Phase II, plus $427,547 security deposit over initial 7-year term.

  Item 2.03 verify on EDGAR →
• medium

  Company has one-time option to terminate lease after 5 years by paying $1.7M termination fee, providing exit flexibility if business needs change.

  Item 1.01 verify on EDGAR →